These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 21131319)
1. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species. Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319 [TBL] [Abstract][Full Text] [Related]
2. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957 [TBL] [Abstract][Full Text] [Related]
3. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody. Nabors GS; Farrell JP Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533 [TBL] [Abstract][Full Text] [Related]
4. Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice. Sodhi S; Ganguly NK; Malla N; Mahajan RC Jpn J Exp Med; 1989 Jun; 59(3):103-8. PubMed ID: 2554031 [TBL] [Abstract][Full Text] [Related]
5. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126 [TBL] [Abstract][Full Text] [Related]
6. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines. Daneshvar H; Coombs GH; Hagan P; Phillips RS J Infect Dis; 2003 May; 187(10):1662-8. PubMed ID: 12721947 [TBL] [Abstract][Full Text] [Related]
7. The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis. Rodrigues RF; Charret KS; Campos MC; Amaral V; Echevarria A; Dos Reis C; Canto-Cavalheiro MM; Leon LL J Antimicrob Chemother; 2012 Jan; 67(1):182-90. PubMed ID: 21987238 [TBL] [Abstract][Full Text] [Related]
8. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. Rachamim N; Jaffe CL J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215 [TBL] [Abstract][Full Text] [Related]
9. In vivo activity of perifosine against Leishmania amazonensis. Cabrera-Serra MG; Valladares B; Piñero JE Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328 [TBL] [Abstract][Full Text] [Related]
10. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis. Eissa MM; Amer EI; El Sawy SM Exp Parasitol; 2011 Aug; 128(4):382-90. PubMed ID: 21620834 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes. Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801 [TBL] [Abstract][Full Text] [Related]
12. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae). Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877 [TBL] [Abstract][Full Text] [Related]
13. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani. Carter KC; Mullen AB; Sundar S; Kenney RT Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684 [TBL] [Abstract][Full Text] [Related]
15. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo. Neal RA; van Bueren J; Hooper G Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778 [TBL] [Abstract][Full Text] [Related]
16. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice. Tonui WK; Titus RG Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887 [TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani: pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo. Morishige K; Aji T; Ishii A; Yasuda T; Wataya Y Exp Parasitol; 1995 Jun; 80(4):665-71. PubMed ID: 7758547 [TBL] [Abstract][Full Text] [Related]
18. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis. Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526 [TBL] [Abstract][Full Text] [Related]